- Report
- August 2025
- 189 Pages
Global
From €3434EUR$3,939USD£2,993GBP
- Report
- September 2025
- 250 Pages
Global
From €3915EUR$4,490USD£3,412GBP
- Report
- January 2025
- 180 Pages
Global
From €3923EUR$4,500USD£3,419GBP
- Report
- December 2023
- 180 Pages
Global
From €1090EUR$1,250USD£950GBP
€2180EUR$2,500USD£1,900GBP
The Fungal Infection Drug market is a subset of the Infectious Diseases Drugs market, which includes drugs used to treat a variety of infectious diseases caused by bacteria, viruses, fungi, and parasites. Fungal Infection Drugs are used to treat fungal infections, which can range from mild to life-threatening. These drugs work by either killing the fungus or preventing its growth. Common fungal infections include athlete's foot, ringworm, and yeast infections.
Fungal Infection Drugs are available in a variety of forms, including tablets, capsules, creams, and ointments. These drugs are typically prescribed by a doctor and can be purchased over-the-counter or online.
Some companies in the Fungal Infection Drug market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Bayer. Show Less Read more